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Abstract
A doubling of Australian expenditure on mental health services over two decades, inflation-adjusted, has reduced prevalence 
of neither psychological distress nor mental disorders. Low rates of help-seeking, and inadequate and inequitable delivery 
of effective care may explain this partially, but not fully. Focusing on depressive disorders, drawing initially on ideas from 
the work of philosopher and socio-cultural critic Ivan Illich, we use evidence-based medicine statistics and simulation 
modelling approaches to develop testable hypotheses as to how iatrogenic influences on the course of depression may 
help explain this seeming paradox. Combined psychological treatment and antidepressant medication may be available, 
and beneficial, for depressed people in socioeconomically advantaged areas. But more Australians with depression live 
in disadvantaged areas where antidepressant medication provision without formal psychotherapy is more typical; there 
also are urban/non-urban disparities. Depressed people often engage in self-help strategies consistent with psychological 
treatments, probably often with some benefit to these people. We propose then, if people are encouraged to rely heavily 
on antidepressant medication only, and if they consequently reduce spontaneous self-help activity, that the benefits of the 
antidepressant medication may be more than offset by reductions in beneficial effects as a consequence of reduced self-
help activity. While in advantaged areas, more comprehensive service delivery may result in observed prevalence lower 
than it would be without services, in less well-serviced areas, observed prevalence may be higher than it would otherwise 
be. Overall, then, we see no change. If the hypotheses receive support from the proposed research, then implications 
for service prioritisation and delivery could include a case for wider application of recovery-oriented practice. Critically, 
it would strengthen the case for action to correct inequities in the delivery of psychological treatments for depression 
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in Australia so that combined psychological therapy and antidepressant medication, accessible and administered within 
an empowering framework, should be a nationally implemented standard.
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Introduction
The paradox: an outline
Australian mental health care expendi-
ture per-person has increased in real 
terms through two decades by nearly 
100%, and by 30% in the last decade 
(Meadows et al., 2018). The National 
Mental Health Strategy and the 
National Action Plan for Mental Health 
have guided large-scale mental health 
care investments, including the Better 
Access to Mental Health Care (‘Better 
Access’) programme, greatly increas-
ing psychological services delivery 
(Jorm, 2018). But, Australian commu-
nity health survey findings suggest no 
change from 2001 to 2014 in preva-
lence of the higher scores on the 
Kessler 10 instrument commonly 
associated with clinically significant 
mental health problems (Meadows 
et al., 2018). The two specific mental 
health surveys conducted in Australia 
in 1997 and 2007 also did not show 
decreasing prevalence (Jorm et  al., 
2017) while population health impact 
of ‘Better Access’ has yet to be 
detected (Jorm, 2018).
So, as others have highlighted in 
this journal, we have a seeming para-
dox to resolve (Mulder et al., 2017): 
why has more expenditure and more 
treatment not led to an identifiable 
decrease in prevalence? This is unlikely 
to have any one explanation. 
Contributory causes may include 
increasing inequality driving an under-
lying prevalence increase (Wilkinson 
and Pickett, 2018), possibly exacer-
bated by social, demographic, cultural 
and environmental changes in the cit-
ies (O’Hanlon, 2018), where most 
Australians live. These might have 
important implication for policy, 
widely framed. Considering health-
care more narrowly, perhaps the 
threshold for a population-level effect 
has not been reached yet (Meadows 
et  al., 2018), but in which case, we 
might ask when might that threshold 
be crossed, and could anything be 
done to bring that time forward?
This paper will focus on healthcare 
planning, delivery and education, 
where there have been proposals for 
major services redesign and reorien-
tation (Van Os et  al., 2019) and the 
suggestion that ‘We need to, at the 
least, consider whether our current men-
tal health systems might be causing unin-
tentional harm in some areas. It is 
possible that in order to achieve better 
outcomes, we need to do less, not more’ 
(Mulder et  al., 2017). We suggest a 
possible contributing mechanism that 
might indeed be causing unintentional 
harm, or iatrogenesis, and so contrib-
uting to this worrying situation. As a 
theoretical contribution in a scientific 
journal, the paper includes testable 
hypotheses. If supported from cur-
rently available or newly collected evi-
dence, these might indicate in some 
cases doing less while suggesting that 
some of the doing might be better 
done differently or more comprehen-
sively. Focusing on depressive disor-
ders as a high-prevalence group of 
problems with a good treatment evi-
dence base, and of indisputable impor-
tance for mental health policy, enables 
us to draw on diagnostic-specific 
sources of evidence. However, the 
findings may have broader implica-
tions diagnostically. Although the 
argument will be developed for 
Australia as a high-income country, 
there may be implications for other 
national contexts.
The active coping strategies of 
the population
People may employ various self-help 
strategies in response to depression, 
some of which might also be advised 
in psychological or psychosocial treat-
ments, such as ‘Doing more things 
you enjoy’, ‘Exercise’, ‘Being with 
pets’ or ‘Meditation’. A cross-sec-
tional community study found that 
with increasing depression severity, 
self-help strategies were reported less 
commonly (Jorm et  al., 2004). The 
explanation suggested for this was 
‘overlapping waves of action’ (Figure 1 
– arrows have been added and are 
discussed later). That is, self-help 
strategies were employed as initial 
responses. If disorder severity 
increased, faith in self-help was 
reduced; these strategies might then 
be abandoned in favour of profes-
sional help-seeking. This then was 
seen as explaining why, among those 
with more severe disorders, self-help 
strategies were less frequently 
reported when rates of professional 
help were higher.
Iatrogenesis considered
During the mid-1970s, the Austrian 
social theorist Ivan Illich (Hartch, 
2015), influential then in social work, 
education and sociology, provided a 
critical perspective on directions 
being taken by modern medicine. 
Proposing that medicalisation of life 
problems had extended beyond the 
bounds of conditions where there 
was convincing evidence that medi-
cine could help, and that in various 
ways the medical establishment was a 
source of disability as much or more 
than of therapeutic benefit, Illich 
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(1976) expanded the concept of iatro-
genesis or physician-caused illness 
beyond prior usage, suggesting a 
threefold nature for iatrogenesis: clin-
ical, social and cultural – of which our 
summary follows.
Clinical iatrogenesis is a regularly 
used concept. Here, we may consider 
medication side effects, whether the 
nausea and sexual dysfunction com-
monly associated with serotonin-spe-
cific reuptake inhibitors or the weight 
gain and metabolic disturbance asso-
ciated with antipsychotics which may 
also be used in treatment of 
depression.
Social iatrogenesis may occur 
where there is a clear expectation 
that people with some aspects of 
experience that become labelled as a 
mental disorder will seek help and pri-
marily address those experiences 
through interactions with professional 
healthcare and the following of given 
advice. Specifically, this becomes iat-
rogenic if the following of this advice 
results in the reliance on an interven-
tion that may on occasions be less 
effective than options for action oth-
erwise in the repertoire of the indi-
vidual or their community resources.
Cultural iatrogenesis can be identi-
fied if we see cultural norms shifting 
such that certain kinds of human 
experience that might be classed as 
normal aspects of the human condi-
tion lose that validated status. Here, 
we may consider the present-day 
functioning of social media with its 
encouragement to present a positive, 
buoyant picture of the self and where 
sharing normal human weaknesses 
and troubles may lead to ostracism 
and ridicule as forms of bullying.
Effectiveness of key interventions 
for depression
Recent meta-analysis work examined 
depression-remission associated with 
antidepressant medications (ADM) 
compared to placebos (Cipriani et al., 
2018). The odds ratio (OR) reported 
for widely currently used ADMs was 
around 1.7. The implied number 
needed to treat (NNT), not provided 
in the article, can be estimated. Given 
the typical response rate in antide-
pressant studies through time of 30–
40% (Furukawa et al., 2016), such an 
OR can be achieved with an NNT of 
8; working: ADM response typically 
47.7% vs 35.0% with placebo; 
OR = (47.7/52.3)/(35.0/65.0) = 1.7; 
absolute risk reduction (ARR) = 47.7–
35.0% = 12.7%; and NNT = 1/ARR = 8. 
So typically, in a group of eight people 
given placebo or ADM for 8 weeks, in 
the placebo group, three will recover; 
while in the ADM group, four will 
recover. This difference might 
increase with more severe depression 
but decrease if diagnosis and treat-
ment in primary mental health care 
were less well controlled than in ana-
lysed studies. NNT for typical psycho-
logical treatments of depression has 
been estimated as around 4 (Cuijpers 
et al., 2016).
Resolving the paradox: 
some contributions
Other ways of framing some of our 
proposals include drawing on con-
cepts from health psychology, the 
social sciences or writings that might 
be termed antipsychiatry. In this 
paper, we concentrate on Illich’s for-
mulation of social iatrogenesis while 
signposting possible influences of clini-
cal and cultural iatrogenesis. We sug-
gest this organising framework is one 
that lends itself to informing an epide-
miological and clinical research 
programme.
We propose that when people 
with depression engage with health-
care delivered within a biomedical 
rather than either a biopsychosocial 
or recovery paradigm, they may trans-
fer expectation of agency for recov-
ery from themselves to the treating 
practitioner and prescribed treat-
ments. They may then reduce their 
application of self-help strategies 
which may have considerable effec-
tiveness for some people. So, the 
reduction in self-help disadvantages 
recovery. If the healthcare provided is 
of high potency for symptom reduc-
tion and functional restoration, this 
may not compromise clinical out-
comes. But, if that care is of marginal 
or even no individual benefit, deliv-
ered in ways that discourage a sense 
of personal efficacy, or if benefit is 
outweighed by effects of clinical iatro-
genesis – then, the overall interven-
tion effect, in a variable number of 
cases, may be negative. In the case of 
ADM monotherapy, negative effects 
would follow if more benefit was lost 
from self-help actions suspended than 
Figure 1. Overlapping waves of action in help-seeking for medical care.
Source: Adapted from Jorm et al. (2004) (Figure 2; p. 298). 
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the ADM effect (NNT ≃ 8, see above). 
Smaller NNTs imply greater effect, so 
self-help actions suspended would 
need to have an NNT less than 8. In 
the case of combined ADM (NNT ≃ 8) 
and psychotherapy (NNT ≃ 4), the 
benefit lost from suspended self-help 
actions would need to be considera-
bly larger for negative effects to 
follow.
While accessible and respected 
Internet sources sometimes empha-
sise active personal and social coping 
strategies, there are prominent exam-
ples where a strong message is con-
veyed that professional help-seeking is 
central to recovery, for example, ‘The 
important thing is finding the right 
treatment and the right health profes-
sional for your needs’ (Beyondblue: 
the national depression initiative, 
2018; italics added). Undoubtedly, 
there are people for whom early 
access to professional care will make 
a real difference to outcome, but, if 
that access is achieved at the cost of 
autonomy and empowerment with 
promotion of passivity in treatment, 
then results may be mixed. Stage-
specific interventions may help deter-
mine who may benefit most from 
which kind of message, but without 
that, we suggest there is potential for 
harm.
To illustrate the proposition, we 
return to Figure 1 and the arrows 
added to this adaptation of the origi-
nal figure. For some people who show 
the combination of professional care 
seeking, lower self-help and increased 
symptoms, it becomes possible that 
their symptom status may be directly 
or indirectly consequential on their 
seeking professional help, rather than 
this help-seeking being a consequence 
of the greater symptoms. The greater 
symptom severity can be a conse-
quence of forms of iatrogenesis, 
rather than – or as well as – a deter-
minant of greater intensity of service 
contact, and a positive feedback loop 
might operate here.
In many socioeconomically disad-
vantaged, regional or remote areas, 
depressed people are more likely to 
get general practitioner (GP) care 
than specialist, interdisciplinary or 
multidisciplinary care. Busy GPs in 
such areas, even if skilled and commit-
ted, may not themselves be able to 
add substantial psychological treat-
ment to ADM prescription while psy-
chology referral may not be available 
(Meadows et al., 2018). Pharmaceutical 
marketing to GPs and medicalised 
public information both will influence 
the patient–doctor interaction. So, 
combined modality treatment – fea-
turing diagnostic caution then desira-
bly nuanced endorsement of ADM 
effects, while respecting and encour-
aging self-help – may be less common 
in such areas. Instead, more simply 
medicalised, potentially iatrogenic, 
treatment may dominate.
Table 1 presents area-specific disad-
vantage quintile rates for elevated psy-
chological-distress and population 
sizes, estimating where people with 
very-high K10 scores live. Thirty per-
cent of those with very-high K10 live in 
areas of greatest disadvantage by quin-
tile, while 9% come from the least dis-
advantaged quintile. Possibly then, 
Table 1. Estimated population by socioeconomic disadvantage quintiles with very-high Kessler 10 scores.
IRSDa quintiles: least (1) to 
greatest (5) disadvantage
Population (2016)
Age: 16–64 yearsb
Estimated population 
% of very-high K10c
Estimated number of people 
with very-high K10d
% of all Australians 
with very-high K10e
Capital cities
1 2,617,180 1.6 41,875 8
2 2,383,572 3.1 73,891 14
3 1,902,530 3.9 74,199 14
4 1,549,484 4.5 69,727 13
5 1,467,165 5.4 79,227 15
Other areas
1 297,417 2.5 7435 1
2 607,052 2.9 17,605 3
3 1,007,006 3.5 35,245 7
4 1,323,931 3.6 47,662 9
5 1,302,272 6.1 79,439 15
Total 14,457,609 526,303 100
aIndex of Relative Socioeconomic Disadvantage.
bAustralian Bureau of Statistics, 2016 Census of Population and Housing, TableBuilder data available at: www.abs.gov.au/websitedbs/censushome.nsf/
home/tablebuilder.
cScores on the Kessler 10 questionnaire above 30, based on 2011 data (Isaacs et al., 2018).
dValues calculated by multiplying column 2 with column 3.
ePercentages calculated by dividing column 3 by total population provided at bottom of column 2.
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more people with depression receive 
limited, potentially iatrogenic care than 
more thorough, comprehensive care 
relatively lacking these risks. People in 
more socioeconomically deprived 
areas may have lower coping resources 
by virtue of educational, status or 
social capital variables, also greater 
income stress and other social deter-
minants of depression. These may indi-
cate more need for interdisciplinary or 
multidisciplinary care rather than less. 
These differential impacts in different 
geographical areas, while objectionable 
on social-justice grounds, might pre-
sent quasi-experimental opportunities 
for collecting evidence bearing on 
these propositions.
This framework for considering 
pathogenic influences would lead us 
to seek practice-models that 
acknowledge risks of harm from 
therapeutic interventions; support 
attention to consumer-defined goals; 
avoid unhelpful biomedical labelling of 
normal life experiences; support social, 
educational and vocational participa-
tion; and encourage people to apply 
themselves energetically to self-help 
and other active strategies in their 
pathway through experiences of men-
tal health problems. Our interventions 
should encourage, not replace or sub-
vert, autonomy, independence and 
active coping. In primary care, this 
could be congruent with principles of 
patient-centred-care; taking here more 
of a specialist-care perspective, there is 
a connection with the constructs of 
personal recovery and recovery-ori-
ented practice (ROP), for instance, as 
developed and implemented in 
Australian specialist mental health care 
(Meadows et  al., 2019). ROP has 
emphasis on consumer-defined goals, 
on a coaching style of relationship 
between providers of care and recipi-
ents, and with domains of concern 
including fostering empowerment and 
a strong sense of identity.
Presenting a research 
programme
We have summarised elements of the 
thinking developed in this paper in a 
causal loop diagram, with some 
explaining notes for this format 
(Figure 2). While qualitative studies 
might usefully contribute to a research 
programme around these ideas, here, 
we concentrate on how we might for-
mulate and test specific hypotheses 
for quantitative investigation.
Self-help may share features with 
effective therapies and be experienced 
as helpful (Houle et  al., 2013; Jorm 
et al., 2004; Morgan et al., 2012). This 
suggests benefit (and possible advan-
tages to promoting helpful strategies), 
but future studies could seek strategy-
specific effect estimates.
Figure 2. Simplified causal loop diagram of the hypothetical nexus.
+/- indicates positive or negative influence through the pathway.
 indicates that the left-hand pathway has greater influence than the right.
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Simulation modelling approaches 
such as agent-based modelling (ABM) 
and system dynamics (SD) may be 
useful here. In Australia, we have little 
in the way of longitudinal data sets, 
but we have extensive and detailed 
national survey data with cross-sec-
tional coverage. Simulation models 
could provide dynamic representa-
tions of the population, bringing 
together best available evidence and 
data with proposed causal models 
including operation of feedback loops. 
Systematic literature reviews and/or 
Delphi studies could be useful 
approaches to inform initial parame-
ter setting. If simulation models gen-
erated values similar to the sequence 
of events that has unfolded in recent 
years, then this would provide, at low 
cost, some support to the hypothe-
ses, while possibility also assisting in 
elaboration of detail of how the influ-
ences might operate separately and 
together. An example hypothesis 
might be that an ABM designed using 
available information on depression 
incidence and available models of 
care, also incorporating social iatro-
genesis elements as described, would 
be found accurately to simulate exist-
ing socioeconomic disparities in 
prevalence.
The original cross-sectional data 
set on self-help (Jorm et  al., 2004) 
could be re-examined, for instance, 
to investigate a hypothesis that data 
from individuals living in areas with 
greater socioeconomic disadvantage 
show a pattern of more severe dis-
order associated with lower active 
self-help and more limited service 
use compared with findings from 
more advantaged areas. But, the 
mechanisms proposed here rely on 
causal connections that may better 
show themselves with longitudinal 
data. A self-help survey (Jorm et al., 
2004) could be repeated and its con-
tent extended within a longitudinal 
design. Examination of associations 
with disparities in psychological 
treatment delivery might allow test-
ing of the hypothesis that combined 
psychological and ADM treatment is 
typically associated with less reduc-
tion in self-help than is ADM treat-
ment alone. It may also, perhaps, 
confirm expectations from efficacy 
studies of better outcomes from 
combined treatment. Useful data 
collection might also be integrated 
into national health surveillance sur-
veys or into any further National 
Survey of Mental Health and 
Wellbeing. Again, inclusion of a lon-
gitudinal design would represent a 
great advantage for examining the 
influences suggested here while 
dynamic simulation models can both 
inform and be informed by such data.
The hypothesis that among people 
with depression those who are more 
activated and empowered consum-
ers have better outcomes could be 
investigated in clinical observational 
studies although there would be con-
siderable design challenges in terms 
of bias and confounding. Arguably, 
most powerful would be intervention 
studies that introduced ROP or asso-
ciated interventions and delivered 
combined treatment in an ROP 
framework in areas that have histori-
cally been deprived of it with explo-
ration of effects on outcome. Here, 
hypotheses might include that ROP 
in primary care for people with 
depression will yield some increase 
where ADM only was provided, but 
have greater benefits in conjunction 
with combined ADM and psycho-
therapeutic treatment.
Implications
Accumulation of evidence for iatro-
genic influences suggested here 
would indicate the need for greater 
cross-government action on equita-
ble services delivery. Inequitable ser-
vice delivery may not only mean 
some areas benefit less but also that 
imbalanced service delivery in 
poorer-serviced areas might there 
do population mental health more 
harm than good. More people with 
depression live in disadvantaged 
areas than advantaged ones, many 
also in regional and remote areas, so 
we may see no overall change from 
increased investment. Increasing 
funding to existing models of care 
may be doomed to failure as a popu-
lation health strategy if health gains in 
areas where care is more often com-
prehensive are more than offset by 
losses in other areas where it is not. 
Increased funding certainly is needed, 
but it should encourage the best ser-
vice models and reach areas of 
greater need. Correcting service 
inequities that are under governmen-
tal control can be very challenging 
(Meadows et al., 2018); for instance, 
for the Australian Government, 
directing where national insurance 
funded health-services are delivered 
faces regulatory, procedural and 
arguably constitutional points of 
resistance (through Article 51:xxiiiA 
and its prohibition of medical ‘civil 
conscription’). A powerful argument 
such as this may be needed to prompt 
such politically difficult action.
ROP is well established in special-
ist mental health care and Australian 
evidence supports effectiveness of 
ROP promotion through training 
interventions (Meadows et al., 2019). 
The arguments set out in the paper 
suggest that there is importance to 
the task of advancing its implementa-
tion in primary mental health care 
(Enticott et al., 2016). We note here 
though that providing depressed 
people in socioeconomically advan-
taged areas with combined ADM and 
psychotherapy while providing ADM 
monotherapy in an ROP framework 
to those in regional, remote or dis-
advantaged areas would be perpetu-
ating an unjust situation. Rather, we 
should work towards ensuring that 
accessible delivery of combined psy-
chosocial interventions and ADM, 
administered within an empowering 
framework and adapted as necessary 
to community needs, is a nationally 
implemented standard rather than a 
notional entitlement accessed only 
by a relatively privileged and better 
located minority of people with 
depression. Both pharmacological 
and psychosocial interventions are 
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also recommended in low- and mid-
dle-income countries, but resource 
and workforce constraints often limit 
activity in the latter; drugs are sim-
pler and quicker to deliver (Patel 
et  al., 2018). Mechanisms proposed 
here might suggest that the sequenc-
ing of these two interventions, and 
the expectations conveyed about 
ADMs, could be important in maxim-
ising health gain from limited invest-
ment. Where data are available, 
simulations could begin the explora-
tion of iatrogenicity in this context 
with field studies to follow.
Conclusion
Proposing some ideas that might go 
towards explaining the seeming par-
adox of why increased expenditure 
and treatment activity have not iden-
tifiably decreased prevalence, we 
have suggested research strategies 
around some described hypotheses. 
If these propositions gain support, 
indicated actions, although variable 
between areas, would include some 
targeted changes to existing service 
distribution and delivery models. 
Increased funding might then be 
invested with greater confidence of 
improving population mental health.
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